NCT02567422 2025-12-04
Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
University of Chicago
University of Chicago
National Cancer Institute (NCI)
Washington University School of Medicine
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute